SMA CARRIER DETECTION BY MLPA / EDTA BLOOD

image not found

NABL Cap Accredited   
The SMA Carrier Detection by MLPA test identifies deletions or copy number changes in the SMN1 gene, which are responsible for Spinal Muscular Atrophy (SMA). This test is recommended for individuals with a family history of SMA or couples planning pregnancy. MLPA (Multiplex Ligation-dependent Probe Amplification) provides highly accurate detection of carrier status. Using EDTA blood, the test helps assess genetic risk and supports informed reproductive decisions

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 9,450.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: S0074

Frequently Asked Questions (FAQ's):

What does this test detect?
It detects SMN1 gene deletions or copy number variations to determine SMA carrier status.

Why is carrier testing important?
Carriers have a risk of passing Spinal Muscular Atrophy to their children, making early detection essential for family planning.

What sample is required?
EDTA blood is needed for DNA extraction and MLPA analysis.

How is MLPA used in this test?
MLPA accurately measures SMN1 gene copy numbers to identify carriers.

Is fasting needed for this test?
No, fasting or special preparation is not required.

Who should consider this test?
Individuals with a family history of SMA, couples planning a child, or partners of confirmed carriers.

Can this test confirm SMA in affected individuals?
No, this test is for carrier detection; diagnostic SMA testing requires additional genetic analysis.

Does Metropolis Healthcare provide this test?
Yes, Metropolis Healthcare offers SMA carrier detection using advanced MLPA technology

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab